Linnea

Linnea®
Vinpocetine

PLANT

Voacanga africana

PART OF THE PLANT USED

Seeds

APPEARANCE

White or slightly yellow crystalline powder

CAS NUMBER

42971-09-5

Linnea® Vinpocetine

Linnea’s Vinpocetine and Vincamine are extracted from Voacanga Africana seeds directly at our Swiss manufacturing site.

Uses

Pharmaceutical

• Cerebrovascular disorders
• Cognitive impairment associated with cerebral vascular disease

Dietary ingredients

• Concentration and memory
• Neuroprotection and brain aging
• Body performance

Products

Pharmaceutical

VINPOCETINE ORAL GRADE
Semi-synthetic derivative

Suitable for oral pharmaceutical forms

VINJECT™ VINPOCETINE
SUITABLE FOR INJECTABLE
Semi-synthetic derivative

Non-sterile suitable for injectable pharmaceutical forms

Dietary Ingredients

VINPOCETINE ORAL GRADE
Semi-synthetic derivative

Suitable for oral pharmaceutical forms

Features

Sustainable, no risk of deforestation

Complies with Ph. Eur. “Vinpocetine” monograph, current edition

Purity grade between 98.5% and 101.5%

get in touch with us

The logo indicates that Linnea is compliant with the European Pharmacopoeia standards for producing Vinpocetine.

Ph. Eur.

The logo indicates that Linnea is CEP certified for producing Vinpocetine. CEP stands for Certificate of Suitability to the monographs of the European Pharmacopoeia.

CEP

The logo indicates that Linnea Natural Pharma Solutions has created a DMF for producing Vinpocetine. DMF stands for Drug Master Files which details information about the manufacturing processes of Linnea.

DMF

The logo indicates that, while producing Vinpocetine, Linnea’s facility remains GMP certified. GMP stands for Good Manufacturing Practices.

GMP compliant by Swissmedic

READ LINNEA’S MEDIA ARCHIVE

Education, Community and Thought Leadership

Linnea goes beyond manufacturing to support our customers, connect with the community, and educate worldwide about the potential therapeutic benefits of our ingredients

follow LINNEA on linkedin

Get the latest
Linnea® news